Cambrex Completes Acquisition of Snapdragon Chemistry, a Leader in Continuous Flow API Development Services
Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has completed its acquisition of Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma customers.
January 18, 2023